XML 105 R84.htm IDEA: XBRL DOCUMENT v3.22.0.1
Share-Based Compensation Plans - Summary of Information Relative to Stock Option Plan Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Number of Options      
Number of Options, Outstanding, January 1 (in shares) 19,446    
Number of Options, Granted (in shares) 4,781    
Number of Options, Exercised (in shares) (3,728)    
Number of Options, Forfeited (in shares) (626)    
Number of Options, Awards transferred to Organon in spin-off (in shares) (1,947)    
Number of Options, Adjustment to Merck awards related to the spin-off of Organon (in shares) 646    
Number of Options, Outstanding, December 31 (in shares) 18,572 19,446  
Number of Options, Vested and expected to vest (in shares) 17,829    
Number of Options, Exercisable (in shares) 12,136    
Weighted Average Exercise Price      
Weighted Average Exercise Price, Options Outstanding, January 1 (in dollars per share) $ 63.64    
Weighted Average Exercise Price, Granted (in dollars per share) 75.99 $ 77.67 $ 80.05
Weighted Average Exercise Price, Exercised (in dollars per share) 54.14    
Weighted Average Exercise Price, Forfeited (in dollars per share) 73.97    
Weighted Average Exercise Price, Awards transferred to Organon in the spin-off (in dollars per share) 72.15    
Weighted Average Exercise Price, Adjustment to Merck awards related to the spin-off of Organon (in dollars per share) 0    
Weighted Average Exercise Price, Options Outstanding, December 31 (in dollars per share) 65.27 $ 63.64  
Weighted Average Exercise Price, Vested and expected to vest (in dollars per share) 64.90    
Weighted Average Exercise Price, Exercisable (in dollars per share) $ 60.41    
Weighted Average Remaining Contractual Term, Outstanding 6 years 3 months 18 days    
Weighted Average Remaining Contractual Term, Vested and expected to vest 6 years 2 months 12 days    
Weighted Average Remaining Contractual Term, Exercisable 5 years    
Aggregate Intrinsic Value, Outstanding $ 213    
Aggregate Intrinsic Value, Vested and expected to vest 212    
Aggregate Intrinsic Value, Exercisable $ 198